drugset / Trial / NCT06619873

A Clinical Study to Evaluate the Relative Bioavailability and Food Effect of HRS-8080 in Healthy Subjects

NCT06619873

Phase 1 Completed 24 enrolled Shandong Suncadia Medicine Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

The study is being conducted to evaluate the relative bioavailability of HRS-8080 in the fasted state in healthy adult subjects and to assess the impact of food on HRS-8080 PK for the Phase 3 capsule in healthy adult.

Timeline

Start
2024-10-10
Primary completion
2024-11-13
Completion
2024-11-13

Drugs

EvaluationDrugModalityDoseRoute
Subject HRS-8080 Unknown 600 mg